Table Of Contents
1 Introduction 17
1.1 Objectives Of The Study 17
1.2 Market Definition 17
1.3 Overview Of Europe Transfection Reagents And Equipment Market 17
1.4 Currency And Pricing 18
1.5 Limitation 18
1.6 Markets Covered 19
2 Market Segmentation 21
2.1 Markets Covered 21
2.2 Geographic Scope 22
2.3 Years Considered For The Study 23
2.4 Currency And Pricing 23
2.5 Research Methodology 24
2.6 Primary Interviews With Key Opinion Leaders 27
2.7 The Category Vs Time Grid 28
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes 34
3.1.2 Increasing R&D Spending And Research Activities By Pharmaceutical And Biotech Companies 35
3.1.3 Technological Advancements In Transfection Technology 36
3.1.4 Alliances Between The Leading Research Institutes To Trigger Drug Discovery 37
3.1.5 Rising Prevalence Of Chronic Indications 37
3.2 Restraints 39
3.2.1 Selective Effectiveness Of Transfection Reagents Or Instruments 39
3.2.2 High Cost Of Transfection Reagents And Equipment 39
3.2.3 Home Brew Reagents Limits The Sale Of Commercial Kits 41
3.3 Opportunities 42
3.3.1 Efficient Nuclear Delivery Method 42
3.3.2 Emerging Markets 42
3.4 Challenges 44
3.4.1 Slow Rate Of Transfection In Hard Cells 44
3.4.2 Cytotoxicity Effects Due To Transfection Reagents 44
4 Executive Summary 45
5 Premium Insights 47
6 Europe Transfection Reagents And Equipment Market, By Product 50
6.1 Overview 51
6.2 Reagent 53
6.3 Equipment 54
7 Europe Transfection Reagents And Equipment Market, By Method 55
7.1 Overview 56
7.2 Physical Method 58
7.2.1 Electroporation 59
7.2.2 Nucleofection 59
7.2.3 Others 59
7.2.3.1 Genegun 60
7.2.3.2 Magnetofection 60
7.2.3.3 Sonoporation 60
7.2.3.4 Optoinjection 60
7.3 Biochemical Methods 61
7.3.1 Lipofection 62
7.3.2 Calcium Phosphate 62
7.3.3 Deae-Dextran 62
7.3.4 Dendrimers 62
7.4 Viral Method 63
7.4.1 Retroviruses 64
7.4.2 Adenoviruses 64
7.4.3 Adenoassociated Viruses 64
7.4.4 Others 64
8 Europe Transfection Reagents And Equipment Market, By Application 65
8.1 Overview 66
8.2 Protein Production 68
8.3 Biomedical Research 69
8.3.1 Gene Expression Studies 70
8.3.2 Cancer Research 70
8.3.3 Transgenic Models 70
8.4 Therapeutic Delivery 71
9 Europe Transfection Reagents And Equipment Market, By End User 72
9.1 Overview 73
9.2 Academics & Research Institutes 75
9.3 Pharmaceutical & Biotechnology Companies 76
10 Europe Transfection Reagents And Equipment, By Geography 77
10.1 Europe 77
10.1.1 Germany 88
10.1.2 U.K. 93
10.1.3 France 98
10.1.4 Italy 103
10.1.5 Spain 108
10.1.6 Switzerland 113
10.1.7 Netherlands 118
10.1.8 Belgium 123
10.1.9 Russia 128
10.1.10 Turkey 133
10.1.11 Rest Of Europe 138
11 Europe Transfection Reagents And Equipment Market, Company Landscape 139
11.1 Company Share Analysis; Europe 139
12 Company Profile 140
12.1 Thermo Fisher Scientific Inc. 140
12.1.1 Company Overview 140
12.1.2 Revenue Analysis 140
12.1.3 Company Share Analysis 141
12.1.4 Product Portfolio 141
12.1.5 Recent Developments 142
12.2 Sigma-Aldrich, Inc. (Subsidiary Of Merck Kgaa) 143
12.2.1 Company Overview 143
12.2.2 Geographical Presence 143
12.2.3 Company Share Analysis 144
12.2.4 Product Portfolio 144
12.2.5 Recent Developments 144
12.3 Promega Corporation 145
12.3.1 Company Overview 145
12.3.2 Geographical Presence 145
12.3.3 Company Share Analysis 146
12.3.4 Product Portfolio 146
12.3.5 Recent Developments 146
12.4 Qiagen 147
12.4.1 Company Overview 147
12.4.2 Revenue Analysis 147
12.4.3 Company Share Analysis 148
12.4.4 Product Portfolio 148
12.4.5 Recent Developments 149
12.5 Bio-Rad Laboratories, Inc. 150
12.5.1 Company Overview 150
12.5.2 Revenue Analysis 150
12.5.3 Product Portfolio 151
12.5.4 Recent Developments 151
12.6 Genlantis Inc. 152
12.6.1 Company Overview 152
12.6.2 Geographical Presence 152
12.6.3 Product Portfolio 153
12.6.4 Recent Developments 153
12.7 Lonza 154
12.7.1 Company Overview 154
12.7.2 Revenue Analysis 154
12.7.3 Product Portfolio 155
12.7.4 Recent Developments 156
12.8 Maxcyte Inc 157
12.8.1 Company Overview 157
12.8.2 Geographical Presence 157
12.8.3 Product Portfolio 158
12.8.4 Recent Developments 158
12.9 Mirus Bio Llc 159
12.9.1 Company Overview 159
12.9.2 Geographical Presence 159
12.9.3 Product Portfolio 160
12.9.4 Recent Developments 161
12.10 Polyplus Transfection 162
12.10.1 Company Overview 162
12.10.2 Geographical Presence 162
12.10.3 Product Portfolio 163
12.10.4 Recent Developments 163
?
12.11 Signagen Laboratories. 164
12.11.1 Company Overview 164
12.11.2 Geographical Presence 164
12.11.3 Product Portfolio 165
12.11.4 Recent Development 165
13 Related Reports 166
?